224 related articles for article (PubMed ID: 32885985)
1. Founder Mutation in N Terminus of Cardiac Troponin I Causes Malignant Hypertrophic Cardiomyopathy.
Fahed AC; Nemer G; Bitar FF; Arnaout S; Abchee AB; Batrawi M; Khalil A; Abou Hassan OK; DePalma SR; McDonough B; Arabi MT; Ware JS; Seidman JG; Seidman CE
Circ Genom Precis Med; 2020 Oct; 13(5):444-452. PubMed ID: 32885985
[TBL] [Abstract][Full Text] [Related]
2. Frequency and clinical expression of cardiac troponin I mutations in 748 consecutive families with hypertrophic cardiomyopathy.
Mogensen J; Murphy RT; Kubo T; Bahl A; Moon JC; Klausen IC; Elliott PM; McKenna WJ
J Am Coll Cardiol; 2004 Dec; 44(12):2315-25. PubMed ID: 15607392
[TBL] [Abstract][Full Text] [Related]
3. Diagnostic disparity and identification of two TNNI3 gene mutations, one novel and one arising de novo, in South African patients with restrictive cardiomyopathy and focal ventricular hypertrophy.
Mouton JM; Pellizzon AS; Goosen A; Kinnear CJ; Herbst PG; Brink PA; Moolman-Smook JC
Cardiovasc J Afr; 2015; 26(2):63-9. PubMed ID: 25940119
[TBL] [Abstract][Full Text] [Related]
4. Clinical features of hypertrophic cardiomyopathy caused by a Lys183 deletion mutation in the cardiac troponin I gene.
Kokado H; Shimizu M; Yoshio H; Ino H; Okeie K; Emoto Y; Matsuyama T; Yamaguchi M; Yasuda T; Fujino N; Ito H; Mabuchi H
Circulation; 2000 Aug; 102(6):663-9. PubMed ID: 10931807
[TBL] [Abstract][Full Text] [Related]
5. A founder MYBPC3 mutation results in HCM with a high risk of sudden death after the fourth decade of life.
Calore C; De Bortoli M; Romualdi C; Lorenzon A; Angelini A; Basso C; Thiene G; Iliceto S; Rampazzo A; Melacini P
J Med Genet; 2015 May; 52(5):338-47. PubMed ID: 25740977
[TBL] [Abstract][Full Text] [Related]
6. Clinical outcomes associated with sarcomere mutations in hypertrophic cardiomyopathy: a meta-analysis on 7675 individuals.
Sedaghat-Hamedani F; Kayvanpour E; Tugrul OF; Lai A; Amr A; Haas J; Proctor T; Ehlermann P; Jensen K; Katus HA; Meder B
Clin Res Cardiol; 2018 Jan; 107(1):30-41. PubMed ID: 28840316
[TBL] [Abstract][Full Text] [Related]
7. Clinical and Prognostic Profiles of Cardiomyopathies Caused by Mutations in the Troponin T Gene.
Ripoll-Vera T; Gámez JM; Govea N; Gómez Y; Núñez J; Socías L; Escandell Á; Rosell J
Rev Esp Cardiol (Engl Ed); 2016 Feb; 69(2):149-58. PubMed ID: 26507537
[TBL] [Abstract][Full Text] [Related]
8. Myocardial late gadolinium enhancement cardiovascular magnetic resonance in hypertrophic cardiomyopathy caused by mutations in troponin I.
Moon JC; Mogensen J; Elliott PM; Smith GC; Elkington AG; Prasad SK; Pennell DJ; McKenna WJ
Heart; 2005 Aug; 91(8):1036-40. PubMed ID: 16020591
[TBL] [Abstract][Full Text] [Related]
9. High prevalence of Arginine to Glutamine substitution at 98, 141 and 162 positions in Troponin I (TNNI3) associated with hypertrophic cardiomyopathy among Indians.
Rani DS; Nallari P; Priyamvada S; Narasimhan C; Singh L; Thangaraj K
BMC Med Genet; 2012 Aug; 13():69. PubMed ID: 22876777
[TBL] [Abstract][Full Text] [Related]
10. Hypertrophic cardiomyopathy: histopathological features of sudden death in cardiac troponin T disease.
Varnava AM; Elliott PM; Baboonian C; Davison F; Davies MJ; McKenna WJ
Circulation; 2001 Sep; 104(12):1380-4. PubMed ID: 11560853
[TBL] [Abstract][Full Text] [Related]
11. Molecular autopsy and family screening in a young case of sudden cardiac death reveals an unusually severe case of FHL1 related hypertrophic cardiomyopathy.
Gaertner-Rommel A; Tiesmeier J; Jakob T; Strickmann B; Veit G; Bachmann-Mennenga B; Paluszkiewicz L; Klingel K; Schulz U; Laser KT; Karger B; Pfeiffer H; Milting H
Mol Genet Genomic Med; 2019 Aug; 7(8):e841. PubMed ID: 31293105
[TBL] [Abstract][Full Text] [Related]
12. Disease penetrance and risk stratification for sudden cardiac death in asymptomatic hypertrophic cardiomyopathy mutation carriers.
Michels M; Soliman OI; Phefferkorn J; Hoedemaekers YM; Kofflard MJ; Dooijes D; Majoor-Krakauer D; Ten Cate FJ
Eur Heart J; 2009 Nov; 30(21):2593-8. PubMed ID: 19666645
[TBL] [Abstract][Full Text] [Related]
13. Sudden death due to troponin T mutations.
Moolman JC; Corfield VA; Posen B; Ngumbela K; Seidman C; Brink PA; Watkins H
J Am Coll Cardiol; 1997 Mar; 29(3):549-55. PubMed ID: 9060892
[TBL] [Abstract][Full Text] [Related]
14. Association of variants in MYH7, MYBPC3 and TNNT2 with sudden cardiac death-related risk factors in Brazilian patients with hypertrophic cardiomyopathy.
Mori AA; Castro LR; Bortolin RH; Bastos GM; Oliveira VF; Ferreira GM; Hirata TDC; Fajardo CM; Sampaio MF; Moreira DAR; Pachón-Mateos JC; Correia EB; Sousa AGMR; Brión M; Carracedo A; Hirata RDC; Hirata MH
Forensic Sci Int Genet; 2021 May; 52():102478. PubMed ID: 33588347
[TBL] [Abstract][Full Text] [Related]
15. Low prevalence and variable clinical presentation of troponin I and troponin T gene mutations in hypertrophic cardiomyopathy.
Curila K; Benesova L; Penicka M; Minarik M; Zemanek D; Veselka J; Widimsky P; Gregor P
Genet Test Mol Biomarkers; 2009 Oct; 13(5):647-50. PubMed ID: 19645627
[TBL] [Abstract][Full Text] [Related]
16. T-peak to T-end interval may be a better predictor of high-risk patients with hypertrophic cardiomyopathy associated with a cardiac troponin I mutation than QT dispersion.
Shimizu M; Ino H; Okeie K; Yamaguchi M; Nagata M; Hayashi K; Itoh H; Iwaki T; Oe K; Konno T; Mabuchi H
Clin Cardiol; 2002 Jul; 25(7):335-9. PubMed ID: 12109867
[TBL] [Abstract][Full Text] [Related]
17. Hypertrophic cardiomyopathy in myosin-binding protein C (
Adalsteinsdottir B; Burke M; Maron BJ; Danielsen R; Lopez B; Diez J; Jarolim P; Seidman J; Seidman CE; Ho CY; Gunnarsson GT
Open Heart; 2020; 7(1):e001220. PubMed ID: 32341788
[TBL] [Abstract][Full Text] [Related]
18. Cardiac troponin I mutations in Australian families with hypertrophic cardiomyopathy: clinical, genetic and functional consequences.
Doolan A; Tebo M; Ingles J; Nguyen L; Tsoutsman T; Lam L; Chiu C; Chung J; Weintraub RG; Semsarian C
J Mol Cell Cardiol; 2005 Feb; 38(2):387-93. PubMed ID: 15698845
[TBL] [Abstract][Full Text] [Related]
19. A new mutation of the cardiac troponin T gene causing familial hypertrophic cardiomyopathy without left ventricular hypertrophy.
Varnava A; Baboonian C; Davison F; de Cruz L; Elliott PM; Davies MJ; McKenna WJ
Heart; 1999 Nov; 82(5):621-4. PubMed ID: 10525521
[TBL] [Abstract][Full Text] [Related]
20. Penetrance of Hypertrophic Cardiomyopathy in Sarcomere Protein Mutation Carriers.
Lorenzini M; Norrish G; Field E; Ochoa JP; Cicerchia M; Akhtar MM; Syrris P; Lopes LR; Kaski JP; Elliott PM
J Am Coll Cardiol; 2020 Aug; 76(5):550-559. PubMed ID: 32731933
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
